Galleon’s Bernstein Joins Healthcare Investment Firm

Jan 27 2010 | 3:39am ET

Healthcare investment firm HealthCor Group has hired a former Galleon Group hedge fund manager.

Jeff Bernstein has joined the $3 billion New York-based firm as a portfolio manager, Bloomberg News reports. HealthCor focuses on the healthcare and life sciences industries; among its investment vehicles is a $300 million private equity fund.

Bernstein spent four years at Galleon in two separate stints. He first joined the New York hedge fund, which closed last year after founder Raj Rajaratnam was charged with insider-trading, in 2000 from Goldman Sachs to manage its New Media fund. He left in 2002 to found his own hedge fund, Keel Capital Management, before returning to Galleon in 2008.

Bernstein was a co-manager of Galleon’s flagship Diversified Fund during his second go-around with the firm.

At least four top Galleon employees, including Bernstein, have joined separate firms this year. Citadel Investment Group hired Charles Benziger, while Soros Fund Management added Eric Wasserstrom and Rajeev Patel. The New York-based firm has been trying—so far without success—to find another firm for its staff to move to.


In Depth

Israeli Hedge Fund Harnesses Big Data

Jul 28 2014 | 8:10am ET

Apica Green is a multi-million dollar Israeli hedge fund that is based in Tel Aviv...

Lifestyle

David Yarrow On Growing His Hedge Fund And Shooting The Animals And People Of Africa - As A Photographer

Jul 23 2014 | 6:44am ET

While he’s always been a photographer, recent expeditions to Iceland, Ethiopia...

Guest Contributor

Compelling Opportunities In The Alternatives Space

Jul 29 2014 | 9:33am ET

In an environment where many asset classes seem expensive by historical standards...

 

Sponsored Content

    Northern Trust Helps Hedge Funds Navigate Derivatives Regulations

    Jul 8 2014 | 10:48am ET

    The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…

Publisher's Note